Wang Jun Lee

Wang Jun Lee

Auto-generated profile, based on publicly available information

Wang Jun Lee

The Office of Chief Executive Officer and Chairman, Department of General Surgery, Myongji Hospital, Hanyang University College of Medicine, Goyang, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JLJaegyun Lim
Jaegyun Lim
SJSeunghyun Jeon
Seunghyun Jeon
SHShin Hyun-Young
Shin Hyun-Young
MKMoon Jung Kim
Moon Jung Kim
YSYu Min Seong
Yu Min Seong
SPSang-Joon Park
Sang-Joon Park
Lim J, et al. J Korean Med Sci. 2020 Jan;35(6):e79. https://doi.org/10.3346/jkms.2020.35.e79


1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YJYoung Hee Jung
Young Hee Jung
EHEun-Hye Ha
Eun-Hye Ha
KCKang Won Choe
Kang Won Choe
Seungbok LeeSeungbok Lee
Seungbok Lee
DJDong Ho Jo
Dong Ho Jo
WLWang Jun Lee
Wang Jun Lee
Jung YH, et al. J Korean Med Sci. 2022 Jun;37(27):e213. https://doi.org/10.3346/jkms.2022.37.e213

1 December 2020 in Journal of Hospital Infection
Verified
Journal Article
Open access
KLK.D. Lee
K.D. Lee
SLS.B. Lee
S.B. Lee
JLJ.K. Lim
J.K. Lim
YKY.M. Kang
Y.M. Kang
IKI.B. Kim
I.B. Kim
WLW.J. Lee
W.J. Lee
We assessed infection control efforts by comparing data collected over 20 weeks during a pandemic under a dual-track healthcare system. A decline in non-COVID-19 patients visiting the emergency department by 37.6% (P<0.01) was observed since admitting COVID-19 cases. However, patients with acute myocardial infarction (AMI), stroke, severe trauma and acute appendicitis presenting for emergency care did not decrease. Door-to-balloon time (34.3 (± 11.3) min vs 22.7 (± 8.3) min) for AMI improved significantly (P<0.01) while door-to-needle time (55.7 (± 23.9) min vs 54.0 (± 18.0) min) in stroke management remained steady (P=0.80). Simultaneously, time-sensitive care involving other clinical services, including patients requiring chemotherapy, radiation therapy and haemodialysis did not change.

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YJYoung Hee Jung
Young Hee Jung
EHEun-Hye Ha
Eun-Hye Ha
JPJunli Park
Junli Park
KCKang Won Choe
Kang Won Choe
WLWang Jun Lee
Wang Jun Lee
DJDong Ho Jo
Dong Ho Jo
Jung YH, et al. J Korean Med Sci. 2023 Mar;38(11):e83. https://doi.org/10.3346/jkms.2023.38.e83

30 June 2024 in Perspectives on Integrative Medicine
Verified
Journal Article
Open access
PDF file
SKSeoyoung Kim
Seoyoung Kim
CSChangon Seo
Changon Seo
HPHyeJin Park
HyeJin Park
JKJin Gwan Kwon
Jin Gwan Kwon
JKJin Kyu Kim
Jin Kyu Kim
SLSanghun Lee
Sanghun Lee
Background: Shilajit is a natural phytocomplex known for centuries in Ayurveda traditional medicine for its antioxidant, immunomodulatory, and neuroprotective properties. However, there is little published scientific evidence to support these acclaimed properties.Methods: The safety, regarding the heavy metal content, component analysis, the neuroprotective effects and amyloid beta (Aβ)-induced cytotoxicity and inflammation of 3 samples of Shilajit derived from different geographical origins were assessed. Neuroprotective effects of Shilajit were examined using neuroblastoma cell lines (SH-SY5Y and IMR-32) and cell viability assays. The inhibitory effect on the proinflammatory cytokine derived from macrophage cells was assessed using bone marrow-derived macrophage cells in vitro and in a murine model of Aβ-induced inflammation (ex vivo analysis).Results: The results showed that a daily dose of each Shilajit sample were within the permissible heavy metal limit established by the United States Food and Drug Administration. The 3 Shilajit samples alleviated Aβ-induced toxicity in neuronal cells. One sample derived from the Altai Mountains suppressed Aβ-induced processing of pro-interleukin (pro-IL)-1β into mature, biologically active IL-1β in macrophages. This Shilajit sample inhibited Aβ-induced production of the proinflammatory cytokine IL-1β in the brain (ex vivo analysis). In component analysis, this sample was enriched in salicyluric acid.Conclusion: Shared and distinct properties were observed among the 3 Shilajit samples concerning their neuroprotective effects, and regarding safety, the daily dose of each Shilajit had a safe level of heavy metal content. Salicyluric acid in Shilajit may be important in mitigating Aβ-induced inflammatory cytokine but more research is necessary.